IL6 and hepatocellular carcinoma: Although a meta-analysis published in 2014 demonstrated that IL-6 –174G>C, not –572G>C, polymorphism was related with HCC susceptibility,[16] controversial results also published thereafter.[17–19] Accordingly, an up-to-date meta-analysis is needed to perform.